2007
Prospective comparison of response rate and long-term results of Velcade and thalidomid based regimens
HÁJEK, Roman; Romana ZAORALOVÁ; Luděk POUR; Hana FILKOVÁ; Henrieta GREŠLIKOVÁ et. al.Basic information
Original name
Prospective comparison of response rate and long-term results of Velcade and thalidomid based regimens
Name in Czech
Srovnání léčebných odpovědí u pacientů s mnohočetným myelomem léčených Velcade a Thalidomidem
Authors
HÁJEK, Roman (203 Czech Republic, guarantor); Romana ZAORALOVÁ (203 Czech Republic); Luděk POUR (203 Czech Republic); Hana FILKOVÁ (203 Czech Republic); Henrieta GREŠLIKOVÁ (703 Slovakia); Pavel NĚMEC (203 Czech Republic); Petr KUGLÍK (203 Czech Republic); Alexandra OLTOVÁ (203 Czech Republic); Zdeněk ADAM (203 Czech Republic); Andrea KŘIVANOVÁ (203 Czech Republic) and Marta KREJČÍ (203 Czech Republic)
Edition
Pavia, Itálie, Haematologica/The Hematology Journal, 2007; Vol.92(6) suppl.2, p. 210-210, 1 pp. 2007
Publisher
Ferrata-Storti Foundation
Other information
Language
English
Type of outcome
Proceedings paper
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Italy
Confidentiality degree
is not subject to a state or trade secret
Impact factor
Impact factor: 5.516
RIV identification code
RIV/00216224:14110/07:00023634
Organization unit
Faculty of Medicine
ISSN
UT WoS
000247425800479
Keywords in English
Multiple myeloma; fluorescence in situ hybridisation; Velcade; Thalidomide
Tags
International impact, Reviewed
Changed: 30/6/2008 09:57, Mgr. Romana Zaoralová
In the original language
Prospective comparison of response rate in multiple myeloma patients and long-term results of Velcade and thalidomid based regimen in Czech republic
In Czech
Práce pojednává o významu nejvýznamnějších chromozomových abnormalit detekovaných pomocí FISH u relabovaných pacientů s léčbou založenou na podávání thalidomidu nebo Velcade.
Links
| LC06027, research and development project |
| ||
| MSM0021622415, plan (intention) |
|